Trevi Therapeutics, Inc.
- Stock
- Ticker TRVI
- Nasdaq
Performance, volatility and drawdowns of Trevi Therapeutics, Inc. since 05/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $113,617. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −95.5% in 02/2022, measured from the peak in 06/2019. It took 76 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -12 | -11 | -14 | -14 | -10 | -15 | -21 | -24 |
| EBITDA | -12 | -11 | -14 | -14 | -10 | -15 | -20 | -24 |
| Net income | -11 | -10 | -12 | -12 | -8.3 | -13 | -18 | -21 |
| Earnings per share | -0.11 | -0.09 | -0.09 | -0.08 | -0.06 | -0.09 | -0.11 | -0.13 |
| Balance sheet | ||||||||
| Total assets | 111 | 107 | 208 | 199 | 193 | 180 | 331 | 311 |
| Liabilities | 11 | 7.5 | 9.8 | 9.6 | 10 | 7.5 | 9.0 | 8.1 |
| Equity | 100 | 99 | 198 | 190 | 183 | 172 | 322 | 303 |
| Cash | 34 | 19 | 117 | 57 | 19 | 19 | 54 | 28 |
| Cash flow | ||||||||
| Operating cash flow | -9.6 | -13 | -10 | -11 | -7.6 | -17 | -17 | -20 |
| Capital expenditure | 0.0 | – | – | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 |
| Free cash flow | -9.6 | -13 | -10 | -11 | -7.6 | -17 | -18 | -20 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +207.5%, weakest 2021 at −67.7%. 3 of 6 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$0.13 |
| 6 Aug 2026 | −$0.11 |
| 5 May 2026 | −$0.09 |
| 17 Mar 2026 | −$0.06 |
| 13 Nov 2025 | −$0.08 |
| 7 Aug 2025 | −$0.09 |
| 8 May 2025 | −$0.09 |
| 18 Mar 2025 | −$0.11 |
| 6 Nov 2024 | −$0.13 |
| 8 Aug 2024 | −$0.12 |
| 7 May 2024 | −$0.11 |
| 20 Mar 2024 | −$0.08 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.7bn
- Market cap in trading currency
- $1.90bn
- Enterprise value
- $1.60bn
- P/E
- –
- P/S
- –
- P/B
- 6.29
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -3.2%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$70.0m
- Net income
- −$60.8m
- Earnings per share
- −$0.39
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -24.7%
- Return on assets
- -19.5%
Balance sheet and cash flow
- Cash
- $299m
- Cash per share
- $2.10
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 38.86
- Book value per share
- $2.12
- Operating cash flow
- −$61.4m
- Free cash flow
- −$61.7m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 143m
- Volume
- 2.07m
- Avg. volume 3 months
- 1.97m
- Relative volume
- 1.0
Price and technicals
- Price
- $13.35
- 1 day
- −2.7%
- 52-week high
- $19.50
- 52-week low
- $9.99
- Distance to 52-week high
- −31.5%
- Distance to 52-week low
- +33.6%
- Distance to 50-day line
- −2.8%
- Distance to 200-day line
- −8.5%
- RSI (14)
- 46
- Volatility 1M
- 71.6%
Performance
- 1 week
- −2.2%
- 1 month
- +3.2%
- 3 months
- −26.2%
- 6 months
- −5.5%
- YTD
- +6.6%
- 1 year
- +20.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has TRVI performed since 05/2019?
$10,000 grew to $16,920 by 20 Nov 2026, which is +7.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is TRVI?
Volatility was 129.9% per year, measured on monthly returns. The largest decline from a peak was −95.5%, with the low in 02/2022.
How does TRVI compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.2% per year at 16.2% volatility, TRVI returned +7.2% at 129.9%. The correlation of monthly returns was 0.07; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.